Cholesterol Biosynthesis: A Mechanistic Overview.

Cholesterol is an essential component of cell membranes and the precursor for the synthesis of steroid hormones and bile acids. The synthesis of this molecule occurs partially in a membranous world (especially the last steps), where the enzymes, substrates, and products involved tend to be extremely hydrophobic. The importance of cholesterol has increased in the past half-century because of its association with cardiovascular diseases, which are considered one of the leading causes of death worldwide. In light of the current need for new drugs capable of controlling the levels of cholesterol in the bloodstream, it is important to understand how cholesterol is synthesized in the organism and identify the main enzymes involved in this process. Taking this into account, this review presents a detailed description of several enzymes involved in the biosynthesis of cholesterol. In this regard, the structure and catalytic mechanism of the enzymes involved in cholesterol biosynthesis, from the initial two-carbon acetyl-CoA building block, will be reviewed and their current pharmacological importance discussed. We believe that this review may contribute to a deeper level of understanding of cholesterol metabolism and that it will serve as a useful resource for future studies of the cholesterol biosynthesis pathway.

[1]  Malte Kelm,et al.  Effects of Proprotein Convertase Subtilisin/Kexin Type 9 Antibodies in Adults With Hypercholesterolemia: A Systematic Review and Meta-analysis. , 2015, Annals of internal medicine.

[2]  Improve-It Investigators Ezetimibe added to statin therapy after acute coronary syndromes , 2015 .

[3]  C. Zeng,et al.  Efficiency and Safety of Proprotein Convertase Subtilisin/Kexin 9 Monoclonal Antibody on Hypercholesterolemia: A Meta-Analysis of 20 Randomized Controlled Trials , 2015, Journal of the American Heart Association.

[4]  G. Ness Physiological feedback regulation of cholesterol biosynthesis: Role of translational control of hepatic HMG-CoA reductase and possible involvement of oxylanosterols. , 2015, Biochimica et biophysica acta.

[5]  C. Wilcox,et al.  Systematic review: the management of chronic diarrhoea due to bile acid malabsorption , 2014, Alimentary Pharmacology and Therapeutics.

[6]  P. Fernandes,et al.  Discovery of new druggable sites in the anti-cholesterol target HMG-CoA reductase by computational alanine scanning mutagenesis , 2014, Journal of Molecular Modeling.

[7]  P. Fernandes,et al.  PLP undergoes conformational changes during the course of an enzymatic reaction. , 2014, Acta crystallographica. Section D, Biological crystallography.

[8]  O. Wiest,et al.  The increasingly complex mechanism of HMG-CoA reductase. , 2013, Accounts of chemical research.

[9]  A. Berghuis,et al.  Thienopyrimidine bisphosphonate (ThPBP) inhibitors of the human farnesyl pyrophosphate synthase: optimization and characterization of the mode of inhibition. , 2013, Journal of medicinal chemistry.

[10]  M. Murthy,et al.  Crystal structures of SCP2-thiolases of Trypanosomatidae, human pathogens causing widespread tropical diseases: the importance for catalysis of the cysteine of the unique HDCF loop. , 2013, The Biochemical journal.

[11]  N. Haginoya,et al.  Discovery of DF-461, a Potent Squalene Synthase Inhibitor. , 2013, ACS medicinal chemistry letters.

[12]  A. Mazein,et al.  A comprehensive machine-readable view of the mammalian cholesterol biosynthesis pathway , 2013, Biochemical pharmacology.

[13]  P. Fernandes,et al.  Unraveling the enigmatic mechanism of L-asparaginase II with QM/QM calculations. , 2013, Journal of the American Chemical Society.

[14]  C. Murray,et al.  Effect of HMG‐CoA reductase inhibitors on antimicrobial susceptibilities for Gram‐Negative rods , 2013, Journal of basic microbiology.

[15]  L. Eriksson,et al.  Catalytic mechanism and product specificity of oxidosqualene-lanosterol cyclase: a QM/MM study. , 2012, The journal of physical chemistry. B.

[16]  Pedro Alexandrino Fernandes,et al.  Computational enzymatic catalysis--clarifying enzymatic mechanisms with the help of computers. , 2012, Physical chemistry chemical physics : PCCP.

[17]  William J. McWhorter,et al.  Structural basis for nucleotide binding and reaction catalysis in mevalonate diphosphate decarboxylase. , 2012, Biochemistry.

[18]  Oliver Nussbaumer,et al.  Novel Aspects of Mevalonate Pathway Inhibitors as Antitumor Agents , 2012, Clinical Cancer Research.

[19]  Leszek Rychlewski,et al.  Squalene monooxygenase – a target for hypercholesterolemic therapy , 2011, Biological chemistry.

[20]  P. Fernandes,et al.  Mechanism of formation of the internal aldimine in pyridoxal 5'-phosphate-dependent enzymes. , 2011, Journal of the American Chemical Society.

[21]  K. Horstman,et al.  The paradox of public health genomics: Definition and diagnosis of familial hypercholesterolaemia in three European countries , 2011, Scandinavian journal of public health.

[22]  R. Russell,et al.  Bisphosphonates: the first 40 years. , 2011, Bone.

[23]  William J. McWhorter,et al.  Crystal Structures of Staphylococcus epidermidis Mevalonate Diphosphate Decarboxylase Bound to Inhibitory Analogs Reveal New Insight into Substrate Binding and Catalysis* , 2011, The Journal of Biological Chemistry.

[24]  P. Fernandes,et al.  Computational Mechanistic Studies Addressed to the Transimination Reaction Present in All Pyridoxal 5'-Phosphate-Requiring Enzymes. , 2011, Journal of chemical theory and computation.

[25]  Trevor J Pugh,et al.  Initial genome sequencing and analysis of multiple myeloma , 2011, Nature.

[26]  E. Oldfield,et al.  Mechanism of action and inhibition of dehydrosqualene synthase , 2010, Proceedings of the National Academy of Sciences.

[27]  P. Clézardin,et al.  How do bisphosphonates inhibit bone metastasis in vivo? , 2010, Neoplasia.

[28]  W. Yue,et al.  Crystal structures of human HMG-CoA synthase isoforms provide insights into inherited ketogenesis disorders and inhibitor design. , 2010, Journal of molecular biology.

[29]  J. Pelkonen,et al.  The level of ATP analog and isopentenyl pyrophosphate correlates with zoledronic acid-induced apoptosis in cancer cells in vitro. , 2009, Bone.

[30]  R. Wierenga,et al.  The thiolase reaction mechanism: the importance of Asn316 and His348 for stabilizing the enolate intermediate of the Claisen condensation. , 2009, Biochemistry.

[31]  J. Medina-Franco,et al.  Inhibitors of HMG-CoA Reductase: Current and Future Prospects. , 2009, Mini reviews in medicinal chemistry.

[32]  J. Urbina,et al.  Ergosterol biosynthesis and drug development for Chagas disease. , 2009, Memorias do Instituto Oswaldo Cruz.

[33]  Supa Hannongbua,et al.  Substrate induced structural and dynamics changes in human phosphomevalonate kinase and implications for mechanism , 2009, Proteins.

[34]  Gordon H Guyatt,et al.  Association between change in high density lipoprotein cholesterol and cardiovascular disease morbidity and mortality: systematic review and meta-regression analysis , 2009, BMJ : British Medical Journal.

[35]  D. Gaudet,et al.  Squalene synthase: a critical enzyme in the cholesterol biosynthesis pathway , 2009, Clinical genetics.

[36]  H. Miziorko,et al.  Human mevalonate diphosphate decarboxylase: characterization, investigation of the mevalonate diphosphate binding site, and crystal structure. , 2008, Archives of biochemistry and biophysics.

[37]  J. Lillehaug,et al.  The protein acetyltransferase ARD1: a novel cancer drug target? , 2008, Current cancer drug targets.

[38]  Cheng-Hsiang Chang,et al.  Importance of Saccharomyces cerevisiae oxidosqualene-lanosterol cyclase tyrosine 707 residue for chair-boat bicyclic ring formation and deprotonation reactions. , 2008, Organic letters.

[39]  D. Liang,et al.  Crystal structure of human phosphomavelonate kinase at 1.8 Å resolution , 2008, Proteins.

[40]  D. Nalin Comment on: unexpected antimicrobial effect of statins. , 2008, The Journal of antimicrobial chemotherapy.

[41]  P. Fernandes,et al.  Computational enzymatic catalysis. , 2008, Accounts of chemical research.

[42]  V. Nizet,et al.  A Cholesterol Biosynthesis Inhibitor Blocks Staphylococcus aureus Virulence , 2008, Science.

[43]  H. Miziorko,et al.  Biochemical and structural basis for feedback inhibition of mevalonate kinase and isoprenoid metabolism. , 2008, Biochemistry.

[44]  J. Cohen,et al.  Unexpected antimicrobial effect of statins. , 2007, The Journal of antimicrobial chemotherapy.

[45]  H. Miziorko,et al.  Functional evaluation of conserved basic residues in human phosphomevalonate kinase. , 2007, Biochemistry.

[46]  Chiaki Nakano,et al.  Sterol Biosynthesis by a Prokaryote: First in Vitro Identification of the Genes Encoding Squalene Epoxidase and Lanosterol Synthase from Methylococcus capsulatus , 2007, Bioscience, biotechnology, and biochemistry.

[47]  Henri Brunengraber,et al.  Localization of the pre-squalene segment of the isoprenoid biosynthetic pathway in mammalian peroxisomes , 2007, Histochemistry and Cell Biology.

[48]  R. Coleman Clinical Features of Metastatic Bone Disease and Risk of Skeletal Morbidity , 2006, Clinical Cancer Research.

[49]  A. Turjanski,et al.  Investigation of the catalytic mechanism of farnesyl pyrophosphate synthase by computer simulation. , 2006, The journal of physical chemistry. B.

[50]  J. Noel,et al.  Structural basis for the design of potent and species-specific inhibitors of 3-hydroxy-3-methylglutaryl CoA synthases. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[51]  G. Ness,et al.  Selective Compensatory Induction of Hepatic HMG-CoA Reductase in Response to Inhibition of Cholesterol Absorption , 2006, Experimental biology and medicine.

[52]  H. Miziorko,et al.  Phosphomevalonate kinase: functional investigation of the recombinant human enzyme. , 2006, Biochemistry.

[53]  I. Hassinen,et al.  A new endogenous ATP analog (ApppI) inhibits the mitochondrial adenine nucleotide translocase (ANT) and is responsible for the apoptosis induced by nitrogen‐containing bisphosphonates , 2006, British journal of pharmacology.

[54]  H. Miziorko,et al.  Investigation of the functional contributions of invariant serine residues in yeast mevalonate diphosphate decarboxylase. , 2005, Biochemistry.

[55]  B. Bahnson An atomic-resolution mechanism of 3-hydroxy-3-methylglutaryl-CoA synthase. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[56]  D. Harrison,et al.  3-hydroxy-3-methylglutaryl-CoA synthase intermediate complex observed in "real-time". , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[57]  T. Schulz-Gasch,et al.  Insight into steroid scaffold formation from the structure of human oxidosqualene cyclase , 2004, Nature.

[58]  V. Rodwell,et al.  The 3-hydroxy-3-methylglutaryl coenzyme-A (HMG-CoA) reductases , 2004, Genome Biology.

[59]  H. Miziorko,et al.  Identification of active site residues in mevalonate diphosphate decarboxylase: Implications for a family of phosphotransferases , 2004, Protein science : a publication of the Protein Society.

[60]  J. Concepción,et al.  In Vitro and In Vivo Activities of E5700 and ER-119884, Two Novel Orally Active Squalene Synthase Inhibitors, against Trypanosoma cruzi , 2004, Antimicrobial Agents and Chemotherapy.

[61]  Ronald J A Wanders,et al.  Phosphomevalonate kinase is a cytosolic protein in humans Published, JLR Papers in Press, January 16, 2004. DOI 10.1194/jlr.M300373-JLR200 , 2004, Journal of Lipid Research.

[62]  D. Hosfield,et al.  Structural Basis for Bisphosphonate-mediated Inhibition of Isoprenoid Biosynthesis* , 2004, Journal of Biological Chemistry.

[63]  R. Thoma,et al.  The monotopic membrane protein human oxidosqualene cyclase is active as monomer. , 2004, Biochemical and biophysical research communications.

[64]  H. Waterham,et al.  Human mevalonate pyrophosphate decarboxylase is localized in the cytosol. , 2004, Molecular genetics and metabolism.

[65]  Ronald J A Wanders,et al.  Mevalonate kinase is a cytosolic enzyme in humans , 2004, Journal of Cell Science.

[66]  Detlef D. Leipe,et al.  Evolution and classification of P-loop kinases and related proteins. , 2003, Journal of molecular biology.

[67]  J. Tobert,et al.  Lovastatin and beyond: the history of the HMG-CoA reductase inhibitors , 2003, Nature Reviews Drug Discovery.

[68]  S. Steinbacher,et al.  Crystal structure of the type II isopentenyl diphosphate:dimethylallyl diphosphate isomerase from Bacillus subtilis. , 2003, Journal of molecular biology.

[69]  E. Oldfield,et al.  Structure and mechanism of action of isopentenylpyrophosphate-dimethylallylpyrophosphate isomerase. , 2003, Journal of the American Chemical Society.

[70]  P. Libby Inflammation in atherosclerosis , 2002, Nature.

[71]  J. Concepción,et al.  Squalene synthase as a chemotherapeutic target in Trypanosoma cruzi and Leishmania mexicana. , 2002, Molecular and biochemical parasitology.

[72]  S. Krisans,et al.  Central role of peroxisomes in isoprenoid biosynthesis. , 2002, Progress in lipid research.

[73]  B. A. Hess,et al.  Concomitant C-ring Expansion and D-ring formation in lanosterol biosynthesis from squalene without violation of Markovnikov's rule. , 2002, Journal of the American Chemical Society.

[74]  Autumn L. Sutherlin,et al.  Enterococcus faecalis 3-Hydroxy-3-Methylglutaryl Coenzyme A Synthase, an Enzyme of Isopentenyl Diphosphate Biosynthesis , 2002, Journal of bacteriology.

[75]  H. Miziorko,et al.  The Structure of a Binary Complex between a Mammalian Mevalonate Kinase and ATP , 2002, The Journal of Biological Chemistry.

[76]  J. Urbina Specific treatment of Chagas disease: current status and new developments , 2001, Current opinion in infectious diseases.

[77]  Joseph L. Goldstein,et al.  The Cholesterol Quartet , 2001, Science.

[78]  J. Deisenhofer,et al.  Structural Mechanism for Statin Inhibition of HMG-CoA Reductase , 2001, Science.

[79]  H. Miziorko,et al.  Investigation of Invariant Serine/Threonine Residues in Mevalonate Kinase , 2001, The Journal of Biological Chemistry.

[80]  B. Clantin,et al.  Crystal structure of isopentenyl diphosphate:dimethylallyl diphosphate isomerase , 2001, The EMBO journal.

[81]  T. Porter,et al.  Inhibition of human squalene monooxygenase by tellurium compounds: evidence of interaction with vicinal sulfhydryls. , 2001, Journal of lipid research.

[82]  J. Deisenhofer,et al.  The structure of the catalytic portion of human HMG-CoA reductase. , 2000, Biochimica et biophysica acta.

[83]  S. Krisans,et al.  Peroxisomal protein targeting and identification of peroxisomal targeting signals in cholesterol biosynthetic enzymes. , 2000, Biochimica et biophysica acta.

[84]  S. Krisans,et al.  Identification of peroxisomal targeting signals in cholesterol biosynthetic enzymes. AA-CoA thiolase, hmg-coa synthase, MPPD, and FPP synthase. , 2000, Journal of lipid research.

[85]  H. Miziorko,et al.  3-Hydroxy-3-methylglutaryl-CoA synthase: participation of invariant acidic residues in formation of the acetyl-S-enzyme reaction intermediate. , 2000, Biochemistry.

[86]  D. Danley,et al.  Crystal Structure of Human Squalene Synthase , 2000, The Journal of Biological Chemistry.

[87]  Y. Modis,et al.  Crystallographic analysis of the reaction pathway of Zoogloea ramigera biosynthetic thiolase. , 2000, Journal of molecular biology.

[88]  I. Abe,et al.  Potent and selective inhibition of squalene epoxidase by synthetic galloyl esters. , 2000, Biochemical and biophysical research communications.

[89]  J. Deisenhofer,et al.  Crystal structure of the catalytic portion of human HMG‐CoA reductase: insights into regulation of activity and catalysis , 2000, The EMBO journal.

[90]  Y. Modis,et al.  A biosynthetic thiolase in complex with a reaction intermediate: the crystal structure provides new insights into the catalytic mechanism. , 1999, Structure.

[91]  L. Tabernero,et al.  Aminoethylcysteine can replace the function of the essential active site lysine of Pseudomonas mevalonii 3-hydroxy-3-methylglutaryl coenzyme A reductase. , 1999, Biochemistry.

[92]  L. Tabernero,et al.  Substrate-induced closure of the flap domain in the ternary complex structures provides insights into the mechanism of catalysis by 3-hydroxy-3-methylglutaryl-CoA reductase. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[93]  K. Gibson,et al.  Characterization of phosphomevalonate kinase: chromosomal localization, regulation, and subcellular targeting. , 1999, Journal of lipid research.

[94]  F. Hegardt Mitochondrial 3-hydroxy-3-methylglutaryl-CoA synthase: a control enzyme in ketogenesis. , 1999, The Biochemical journal.

[95]  G. Schulz,et al.  The structure of the membrane protein squalene-hopene cyclase at 2.0 A resolution. , 1999, Journal of molecular biology.

[96]  G. Ness,et al.  Dietary cholesterol regulates hepatic 3-hydroxy-3-methylglutaryl coenzyme A reductase gene expression in rats primarily at the level of translation. , 1998, Archives of biochemistry and biophysics.

[97]  W. L. Jorgensen,et al.  Computational Investigations of Carbenium Ion Reactions Relevant to Sterol Biosynthesis , 1997 .

[98]  T. Hashimoto,et al.  Medium Chain 3-Ketoacyl-Coenzyme A Thiolase Deficiency: A New Disorder of Mitochondrial Fatty Acid β-Oxidation , 1997, Pediatric Research.

[99]  H. Miziorko,et al.  Identification of Catalytic Residues in Human Mevalonate Kinase* , 1997, The Journal of Biological Chemistry.

[100]  E. Waelkens,et al.  Substrate Specificities of 3-Oxoacyl-CoA Thiolase A and Sterol Carrier Protein 2/3-Oxoacyl-CoA Thiolase Purified from Normal Rat Liver Peroxisomes , 1997, Journal of Biological Chemistry.

[101]  G. Ness,et al.  Translational regulation of hepatic HMG-CoA reductase by dietary cholesterol. , 1997, Biochemical and biophysical research communications.

[102]  H. Miziorko,et al.  Identification and Functional Characterization of an Active-site Lysine in Mevalonate Kinase* , 1997, The Journal of Biological Chemistry.

[103]  J C Sacchettini,et al.  Regulation of product chain length by isoprenyl diphosphate synthases. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[104]  G. Smith,et al.  Inhibition of squalene synthase of rat liver by novel 3' substituted quinuclidines. , 1996, Biochemical pharmacology.

[105]  G. Ness,et al.  Farnesol is not the nonsterol regulator mediating degradation of HMG-CoA reductase in rat liver. , 1996, Archives of biochemistry and biophysics.

[106]  J. Rine,et al.  The biology of HMG-CoA reductase: the pros of contra-regulation. , 1996, Trends in biochemical sciences.

[107]  J. Sakakibara,et al.  Purification and characterization of recombinant squalene epoxidase. , 1995, Journal of lipid research.

[108]  G. Ness,et al.  Effect of squalene synthase inhibition on the expression of hepatic cholesterol biosynthetic enzymes, LDL receptor, and cholesterol 7 alpha hydroxylase. , 1994, Archives of biochemistry and biophysics.

[109]  P. Edwards,et al.  Farnesyl-diphosphate synthase is localized in peroxisomes. , 1994, The Journal of biological chemistry.

[110]  V. Rodwell,et al.  Catalysis by Syrian hamster 3-hydroxy-3-methylglutaryl-coenzyme A reductase. Proposed roles of histidine 865, glutamate 558, and aspartate 766. , 1994, The Journal of biological chemistry.

[111]  C. Poulter,et al.  Yeast farnesyl-diphosphate synthase: site-directed mutagenesis of residues in highly conserved prenyltransferase domains I and II. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[112]  G. Prestwich,et al.  ENZYMATIC CYCLIZATION OF SQUALENE AND OXIDOSQUALENE TO STEROLS AND TRITERPENES , 1993 .

[113]  H. Miziorko,et al.  Avian 3-hydroxy-3-methylglutaryl-CoA synthase. Characterization of a recombinant cholesterogenic isozyme and demonstration of the requirement for a sulfhydryl functionality in formation of the acetyl-enzyme reaction intermediate. , 1993, The Journal of biological chemistry.

[114]  P. Evans,et al.  Site-directed mutagenesis identifies catalytic residues in the active site of Escherichia coli phosphofructokinase. , 1992, Biochemistry.

[115]  V. Rodwell,et al.  Identification of the catalytically important histidine of 3-hydroxy-3-methylglutaryl-coenzyme A reductase. , 1992, The Journal of biological chemistry.

[116]  Y. Yamori,et al.  Liver mevalonate 5-pyrophosphate decarboxylase is responsible for reduced serum cholesterol in stroke-prone spontaneously hypertensive rat. , 1992, The Journal of biological chemistry.

[117]  N. Ryder,et al.  Terbinafine: Mode of action and properties of the squalene epoxidase inhibition , 1992, The British journal of dermatology.

[118]  Y. Sawasaki,et al.  Hypolipidemic effects of NB-598 in dogs. , 1991, Atherosclerosis.

[119]  V. Rodwell,et al.  Identification of the principal catalytically important acidic residue of 3-hydroxy-3-methylglutaryl coenzyme A reductase. , 1990, The Journal of biological chemistry.

[120]  C. Poulter,et al.  Hydrogen exchange during the enzyme-catalyzed isomerization of isopentenyl diphosphate and dimethylallyl diphosphate , 1990 .

[121]  Y. Iwasawa,et al.  NB-598: a potent competitive inhibitor of squalene epoxidase. , 1990, The Journal of biological chemistry.

[122]  C. Poulter Biosynthesis of non-head-to-tail terpenes. Formation of 1'-1 and 1'-3 linkages , 1990 .

[123]  J. Goldstein,et al.  Regulation of the mevalonate pathway , 1990, Nature.

[124]  K. Svenson,et al.  Identification of a zinc finger protein that binds to the sterol regulatory element. , 1989, Science.

[125]  C. Walsh,et al.  Mechanistic studies on beta-ketoacyl thiolase from Zoogloea ramigera: identification of the active-site nucleophile as Cys89, its mutation to Ser89, and kinetic and thermodynamic characterization of wild-type and mutant enzymes. , 1989, Biochemistry.

[126]  T. Osborne,et al.  Operator constitutive mutation of 3-hydroxy-3-methylglutaryl coenzyme A reductase promoter abolishes protein binding to sterol regulatory element. , 1988, The Journal of biological chemistry.

[127]  P. Hartlage,et al.  Mitochondrial acetoacetyl-CoA thiolase deficiency. , 1986, Biochemical medicine and metabolic biology.

[128]  R. Abeles,et al.  Mechanism of action of isopentenyl pyrophosphate isomerase: evidence for a carbonium ion intermediate. , 1986, Biochemistry.

[129]  H. Brewer,et al.  In vivo modulation of rat liver 3-hydroxy-3-methylglutaryl-coenzyme A reductase, reductase kinase, and reductase kinase kinase by mevalonolactone. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[130]  E. E. Tamelen BIOORGANIC CHARACTERIZATION AND MECHANISM OF THE 2,3-OXIDOSQUALENE → LANOSTEROL CONVERSION , 1983 .

[131]  M. Brown,et al.  Regulation of synthesis and degradation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase by low density lipoprotein and 25-hydroxycholesterol in UT-1 cells. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[132]  W. Cleland,et al.  pH properties and chemical mechanism of action of 3-hydroxy-3-methylglutaryl coenzyme A reductase. , 1981, Biochemistry.

[133]  C. Poulter,et al.  Farnesyl pyrophosphate synthetase. Mechanistic studies of the 1′-4 coupling reaction in the terpene biosynthetic pathway [13] , 1979 .

[134]  E. E. Tamelen,et al.  Generation of the onocerin system by lanosterol 2,3-oxidosqualene cyclase - implications for the cyclization process , 1979 .

[135]  M. Brown,et al.  Induction of 3-hydroxy-3-methylglutaryl coenzyme A reductase activity in human fibroblasts incubated with compactin (ML-236B), a competitive inhibitor of the reductase. , 1978, The Journal of biological chemistry.

[136]  M. Astruc,et al.  Squalene epoxidase and oxidosqualene lanosterol-cyclase activities in cholesterogenic and non-cholesterogenic tissues. , 1977, Biochimica et biophysica acta.

[137]  M. Lane,et al.  3-Hydroxy-3-methylgutaryl-CoA synthase. Participation of acetyl-S-enzyme and enzyme-S-hydroxymethylgutaryl-SCoA intermediates in the reaction. , 1977, The Journal of biological chemistry.

[138]  E. E. Tamelen,et al.  Overall mechanism of terpenoid terminal epoxide polycyclizations , 1977 .

[139]  C. Ramachandran,et al.  Decarboxylation of mevalonate pyrophosphate is one rate-limiting step in hepatic cholesterol synthesis in suckling and weaned rats. , 1976, Biochemical and biophysical research communications.

[140]  M. Lane,et al.  3-Hydroxy-3-methylglutaryl coenzyme A synthase. Evidence for an acetyl-S-enzyme intermediate and identification of a cysteinyl sulfhydryl as the site of acetylation. , 1975, The Journal of biological chemistry.

[141]  K. Bloch,et al.  Solubilization and partial characterization of rat liver squalene epoxidase. , 1975, The Journal of biological chemistry.

[142]  A. Grieder,et al.  Cyclization of a terpenoid diene with preformed A-B-D rings and its significance for the mechanism of terpenoid terminal epoxide cyclizations , 1974 .

[143]  W. Cleland,et al.  Purification and mechanism of action of hog liver mevalonic kinase. , 1970, The Journal of biological chemistry.

[144]  J. D. Willett,et al.  On the mechanism of lanosterol biosynthesis from squalene 2,3-oxide. , 1967, Journal of the American Chemical Society.

[145]  M. Schwartz,et al.  Nonenzymic laboratory cyclization of squalene 2,3-oxide. , 1966, Journal of the American Chemical Society.

[146]  E. Corey,et al.  2,3-oxidosqualene, an intermediate in the biological synthesis of sterols from squalene. , 1966, Journal of the American Chemical Society.

[147]  K. Bloch,et al.  THE ENZYMATIC CONVERSION OF MEVALONIC ACID TO SQUALENE , 1957 .

[148]  D. Płochocka,et al.  Farnesyl diphosphate synthase; regulation of product specificity. , 2005, Acta biochimica Polonica.

[149]  A. Chugh,et al.  Squalene epoxidase as hypocholesterolemic drug target revisited. , 2003, Progress in lipid research.

[150]  M. Hedl,et al.  3-Hydroxy-3-methylglutaryl-CoA reductase. , 2000, Methods in enzymology.

[151]  D. Strickland,et al.  The mammalian low-density lipoprotein receptor family. , 1999, Annual review of nutrition.

[152]  J. Trzăskos,et al.  Effects of 15-oxa-32-vinyl-lanost-8-ene-3 beta,32 diol on the expression of 3-hydroxy-3-methylglutaryl coenzyme A reductase and low density lipoprotein receptor in rat liver. , 1998, Archives of biochemistry and biophysics.

[153]  T. Hashimoto,et al.  Characterization of N93S, I312T, and A333P missense mutations in two Japanese families with mitochondrial acetoacetyl‐CoA thiolase deficiency , 1998, Human mutation.

[154]  A. Palotie,et al.  Long-chain 3-hydroxyacyl-coenzyme A dehydrogenase deficiency with the G1528C mutation: clinical presentation of thirteen patients. , 1997, The Journal of pediatrics.

[155]  J. D. Karkas,et al.  Zaragozic acids: a family of fungal metabolites that are picomolar competitive inhibitors of squalene synthase. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[156]  D. Gordon,et al.  High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies. , 1989, Circulation.